Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK-0677 in Stage 4 and 5 Chronic Kidney Disease
NCT01343641Phase 2Withdrawn
- Sponsor
- University of Virginia
- Start
- Mar 2009
- Primary completion
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ibutamoren in chronic kidney disease (CKD), sponsored by University of Virginia. Planned start Mar 2009; status: withdrawn.
02
Drugs
ibutamoren
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT01343641.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01343641.